Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Pankaj Bhardwaj and Praveen Sharma.
Pankaj Bhardwaj
Connection Strength
0.233
Praveen Sharma
  1. Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database. Expert Opin Drug Saf. 2021 Sep; 20(9):1125-1136.
    View in: PubMed
    Score: 0.060
  2. Adverse Events Reported From  COVID-19 Vaccine Trials: A Systematic Review. Indian J Clin Biochem. 2021 Oct; 36(4):427-439.
    View in: PubMed
    Score: 0.059
  3. Rapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications. Expert Rev Clin Pharmacol. 2021 Jan; 14(1):95-103.
    View in: PubMed
    Score: 0.058
  4. Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database. Infect Drug Resist. 2020; 13:4427-4438.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.